Selected article for: "antifungal combination and combination therapy"
Author: Suzuki, Atsushi; Kimura, Tomoki; Kataoka, Kensuke; Matsuda, Toshiaki; Yokoyama, Toshiki; Mori, Yuta; Kondoh, Yasuhiro
Title: Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema
  • Cord-id: 8jcb0zef
  • Document date: 2018_1_31
    • ID: 8jcb0zef
    Snippet: Acute exacerbation (AE) is a severe and life-threatening complication of idiopathic pulmonary fibrosis (IPF). In 2016, the definition and diagnostic criteria for AE-IPF were updated by an international working group. The new definition includes any acute, clinically significant respiratory deterioration (both idiopathic and triggered events) characterized by evidence of new widespread alveolar abnormality in patients with IPF. There are no currently proven beneficial management strategies for id
    Document: Acute exacerbation (AE) is a severe and life-threatening complication of idiopathic pulmonary fibrosis (IPF). In 2016, the definition and diagnostic criteria for AE-IPF were updated by an international working group. The new definition includes any acute, clinically significant respiratory deterioration (both idiopathic and triggered events) characterized by evidence of new widespread alveolar abnormality in patients with IPF. There are no currently proven beneficial management strategies for idiopathic and triggered AE-IPF. This is the first report describing AE-IPF triggered by Aspergillus empyema, which was improved by a combination of corticosteroid, systemic antifungal therapy, local antifungal therapy, and additional pharmacological therapies. Future research may reveal optimal strategies for both idiopathic and triggered AE-IPF.

    Search related documents:
    Co phrase search for related documents
    • abnormal dyspnea and lung disease: 1, 2
    • acute exacerbation and low quality: 1, 2, 3
    • acute exacerbation and low quality evidence: 1, 2
    • acute exacerbation and lung biopsy: 1
    • acute exacerbation and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute exacerbation and lung field: 1, 2
    • low quality and lung disease: 1, 2, 3, 4
    • low quality and lung field: 1